Antibody Treatment Could Fight Rare But Deadly Bile Duct Cancers
MONDAY, June 12, 2023 (HealthDay News) — Patients with bile duct cancer might soon have an additional treatment available to them, thanks to a newly discovered tumor target.Some bile duct cancers are driven by a mutated HER2 gene, which has also been…
Learn MoreLocally Recurrent Rectal Cancer QoL Is Valid Patient-Reported Outcome Measure
FRIDAY, June 9, 2023 (HealthDay News) — A new locally recurrent rectal cancer (LRRC) quality of life (QoL) measure is a valid patient-reported outcome measure (PROM), according to a study published in the May issue of eClinicalMedicine.Deena P. Harji…
Learn MoreLos centros oncológicos advierten que la escasez de fármacos afecta a la atención del paciente
JUEVES, 8 de junio de 2023 (HealthDay News) — Una nueva encuesta de centros oncológicos encuentra que la escasez de quimioterapia está afectando a la mayoría, y que provoca cambios de último minuto en los tratamientos de numerosos tipos de cáncer. Má…
Learn MoreASCO: FOLFOX Noninferior to Chemoradiotherapy for Overall Survival in Rectal Cancer
FRIDAY, June 9, 2023 (HealthDay News) — Neoadjuvant chemotherapy with fluorouracil, leucovorin, and oxaliplatin (FOLFOX) is noninferior to preoperative chemoradiotherapy with respect to overall survival for patients with locally advanced rectal cance…
Learn MoreASCO: Adding Atezolizumab to Cabozantinib No Benefit in Advanced Renal Cancer
FRIDAY, June 9, 2023 (HealthDay News) — For patients with locally advanced or metastatic renal cell carcinoma with disease progression on or after immune checkpoint inhibitor treatment, the addition of atezolizumab to cabozantinib does not improve cl…
Learn More2 Years of Immunotherapy for Advanced Lung Cancer Might Be Enough: Study
FRIDAY, June 9, 2023 (HealthDay News) — For patients battling late-stage lung cancer, prospects for survival have improved significantly since the advent of medications known as immune checkpoint inhibitors.But exactly how long patients with advanced…
Learn MoreUkraine: The War on Cancer, Fought in a War Zone
FRIDAY, June 9, 2023 (HealthDay News) — Dr. Olena Postuypalenko was caring for patients at Kyiv City Clinical Oncology Center on Feb. 24, 2022, when her mother called to ask what seemed like an odd question: Has Russia invaded Ukraine?“My mom called …
Learn MoreDisability a Growing Concern for U.S. Cancer Survivors
FRIDAY, June 9, 2023 (HealthDay News) — The percentage of cancer survivors who struggle with a disability has doubled in the past 20 years, new research shows.“The fact that we are saving more lives from cancer is worth celebrating, but it also warra…
Learn MoreLong Space Flights Could Take Toll on Astronauts’ Brains
FRIDAY, June 9, 2023 (HealthDay News) — Astronauts spending six months or longer in space should stretch their time between trips to three years, warns new research on the impact of space travel on the brain.To study this, researchers examined the br…
Learn MoreMany Cancer Centers Experiencing Shortage of Carboplatin, Cisplatin
THURSDAY, June 8, 2023 (HealthDay News) — Ninety-three and 70 percent of cancer centers are currently experiencing a shortage of carboplatin and cisplatin, respectively, according to a report published June 7 by the National Comprehensive Cancer Netw…
Learn More